PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice, page-8

  1. 2,164 Posts.
    lightbulb Created with Sketch. 161
    A bit late to the party but I did chase this one today at the open. For me, it’s all about the risk/reward ratio. Most bios fail at the Phase II stage. Phase III isn’t without risk but if successful, it could be blockbuster returns. So, happy to put some money here.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.